Cite
Effectiveness of HA330 hemoperfusion as an adjunctive therapy for severe COVID-19 patients: a single center experience.
MLA
Phongphithakchai, Atthaphong, et al. “Effectiveness of HA330 Hemoperfusion as an Adjunctive Therapy for Severe COVID-19 Patients: A Single Center Experience.” Anaesthesia, Pain & Intensive Care, vol. 28, no. 2, Apr. 2024, pp. 265–71. EBSCOhost, https://doi.org/10.35975/apic.v28i2.2429.
APA
Phongphithakchai, A., Saelue, P., Wongpraphairot, S., & Boonsrirat, U. (2024). Effectiveness of HA330 hemoperfusion as an adjunctive therapy for severe COVID-19 patients: a single center experience. Anaesthesia, Pain & Intensive Care, 28(2), 265–271. https://doi.org/10.35975/apic.v28i2.2429
Chicago
Phongphithakchai, Atthaphong, Pirun Saelue, Suwikran Wongpraphairot, and Ussanee Boonsrirat. 2024. “Effectiveness of HA330 Hemoperfusion as an Adjunctive Therapy for Severe COVID-19 Patients: A Single Center Experience.” Anaesthesia, Pain & Intensive Care 28 (2): 265–71. doi:10.35975/apic.v28i2.2429.